Treatment of psoriasis with anti-TNF drugs during pregnancy: case report and review of the literature

Dermatology : International Journal for Clinical and Investigative Dermatology
Lluís PuigAgustín Alomar

Abstract

Published experiences of TNF-alpha inhibition during pregnancy consist of a limited number of case reports, series and ongoing registry data in patients with arthritis and inflammatory bowel disease. A 28-year-old woman - with psoriasis vulgaris since she was 8 years of age and generalized pustular psoriasis during her first pregnancy (partially controlled with ciclosporin, oral prednisone and topical corticosteroids, when lupus anticoagulant was detected at another hospital) - presented 4 months after delivery with severe psoriasis (PASI = 15.4) that did not respond to ciclosporin (3 mg/kg/day). Ten days after the first infusion of infliximab (5 mg/kg), when the patient became aware that she was pregnant again, there was PASI75 response, and the patient wished to continue this treatment after being fully informed. Complete blanching was achieved by week 6 of treatment, and was maintained thereafter until the moment of writing (19 months after the start of treatment). She gave birth by caesarean delivery to a healthy female baby, who was breastfed for 1 month and has developed normally. The current report extends the available evidence on successful infliximab treatment in pregnant women, with the first case of a patient with p...Continue Reading

Citations

Sep 6, 2013·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Marina PapoutsakiAntonio Costanzo
Mar 27, 2012·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·T Ness, W Paulus
Feb 25, 2011·Current Opinion in Rheumatology·Monika Ostensen, Frauke Förger
May 16, 2013·World Journal of Gastroenterology : WJG·Renée M Marchioni, Gary R Lichtenstein
Dec 10, 2013·Actas dermo-sifiliográficas·V RuizL Puig
Feb 3, 2012·Immunopharmacology and Immunotoxicology·Giampiero GirolomoniGino Antonio Vena
Jan 24, 2012·Cutaneous and Ocular Toxicology·Kubra BozdagMurat Ermete
May 31, 2011·Reproductive Toxicology·Nada DjokanovicGideon Koren
May 22, 2010·Actas dermo-sifiliográficas·L PuigJ M Carrascosa
Apr 11, 2014·The Journal of Investigative Dermatology·Kazumitsu SugiuraMasashi Akiyama
Aug 7, 2013·Dermatologic Therapy·Stephanie Lehrhoff, Miriam Keltz Pomeranz
Jan 1, 2012·Translational Vision Science & Technology·Harish RajaJose S Pulido
May 1, 2016·The Journal of Dermatology·Akimasa AdachiMamitaro Ohtsuki
Oct 22, 2016·Actas dermo-sifiliográficas·B Echeverría-GarcíaUNKNOWN Grupo de estudio BIOBADADERM
Jan 11, 2017·Dermatologic Therapy·Tamara Lund, Simon Francis Thomsen
Aug 12, 2016·Obstetric Medicine·Aoibheann FlynnLouise Barnes
Apr 16, 2011·Dermatology : International Journal for Clinical and Investigative Dermatology·Y H HuangC C Hsieh
Sep 20, 2018·The Journal of Dermatology·Hideki FujitaUNKNOWN Japanese Dermatological Association Guidelines Development Committee for the Guidelines for the Management and Treatment of
Oct 14, 2016·Hypertension·Michaela GolicRalf Dechend
Jun 6, 2020·Journal of Cutaneous Medicine and Surgery·Jensen YeungRonald Vender
May 15, 2020·Dermatologic Therapy·Goncagul Babuna Kobaner, Algun Polat Ekinci
Jul 10, 2020·The Journal of International Medical Research·Xinjing YaoYing Chen
Jul 4, 2020·Expert Opinion on Drug Safety·Wen-Ming Wang, Hong-Zhong Jin
Jul 22, 2018·International Journal of Dermatology·Tamayo YamashitaKeiji Iwatsuki
May 29, 2020·Neurology. Neuroimmunology and Neuroinflammation·Sara C LaHueRiley Bove
Jun 23, 2019·Current Hypertension Reports·Laura E CoatsBarbara T Alexander
Jun 1, 2018·Dermatology Research and Practice·Nastaran Namazi, Sahar Dadkhahfar
Sep 16, 2014·Deutsches Ärzteblatt International·Friederike MackensenThomas Ness
Aug 18, 2021·Expert Review of Clinical Immunology·Mayumi Komine, Akimichi Morita
Aug 28, 2021·Medicina·Anca Angela SimionescuAna Maria Alexandra Stanescu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

© 2022 Meta ULC. All rights reserved